<DOC>
	<DOC>NCT00658788</DOC>
	<brief_summary>The primary objectives of this study are to evaluate the safety &amp; efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.</brief_summary>
	<brief_title>Safety &amp; Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis</brief_title>
	<detailed_description>Same as above.</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Diagnosis of moderate to severe plaque psoriasis, defined as 3% 20% treatable body surface area Overall Disease Severity of at least 3 (moderate) Surface area involvement too large (&gt;20% BSA) Psoriasis involving only the scalp, groin, axillae, and/or other intertriginous areas</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>